BACKGROUND: The brush border enzyme intestinal alkaline phosphatase (IAP) functions as a gut mucosal defense factor and is protective against dextran sulfate sodium (DSS)-induced acute injury in rats. The present study evaluated the potential therapeutic role for orally administered calf IAP (cIAP) in two independent mouse models of chronic colitis: 1) DSS-induced chronic colitis, and 2) chronic spontaneous colitis in Wiskott-Aldrich Syndrome protein (WASP)-deficient (knockout) mice that is accelerated by irradiation. METHODS: The wildtype (WT) and IAP knockout (IAP-KO) mice received four cycles of 2% DSS ad libitum for 7 days. Each cycle was followed by a 7-day DSS-free interval during which mice received either cIAP or vehicle in the drinking water. The WASP-KO mice received either vehicle or cIAP for 6 weeks beginning on the day of irradiation. RESULTS: Microscopic colitis scores of DSS-treated IAP-KO mice were higher than DSS-treated WT mice (52±3.8 versus 28.8±6.6, respectively, P<0.0001). cIAP treatment attenuated the disease in both groups (KO=30.7±6.01, WT=18.7±5.0, P<0.05). In irradiated WASP-KO mice cIAP also attenuated colitis compared to control groups (3.3±0.52 versus 6.2±0.34, respectively, P<0.001). Tissue myeloperoxidase activity and proinflammatory cytokines were significantly decreased by cIAP treatment. CONCLUSIONS: Endogenous IAP appears to play a role in protecting the host against chronic colitis. Orally administered cIAP exerts a protective effect in two independent mouse models of chronic colitis and may represent a novel therapy for human IBD.
BACKGROUND: The brush border enzyme intestinal alkaline phosphatase (IAP) functions as a gut mucosal defense factor and is protective against dextran sulfate sodium (DSS)-induced acute injury in rats. The present study evaluated the potential therapeutic role for orally administered calfIAP (cIAP) in two independent mouse models of chronic colitis: 1) DSS-induced chronic colitis, and 2) chronic spontaneous colitis in Wiskott-Aldrich Syndrome protein (WASP)-deficient (knockout) mice that is accelerated by irradiation. METHODS: The wildtype (WT) and IAP knockout (IAP-KO) mice received four cycles of 2% DSS ad libitum for 7 days. Each cycle was followed by a 7-day DSS-free interval during which mice received either cIAP or vehicle in the drinking water. The WASP-KO mice received either vehicle or cIAP for 6 weeks beginning on the day of irradiation. RESULTS: Microscopic colitis scores of DSS-treated IAP-KO mice were higher than DSS-treated WT mice (52±3.8 versus 28.8±6.6, respectively, P<0.0001). cIAP treatment attenuated the disease in both groups (KO=30.7±6.01, WT=18.7±5.0, P<0.05). In irradiated WASP-KO mice cIAP also attenuated colitis compared to control groups (3.3±0.52 versus 6.2±0.34, respectively, P<0.001). Tissue myeloperoxidase activity and proinflammatory cytokines were significantly decreased by cIAP treatment. CONCLUSIONS: Endogenous IAP appears to play a role in protecting the host against chronic colitis. Orally administered cIAP exerts a protective effect in two independent mouse models of chronic colitis and may represent a novel therapy for human IBD.
Authors: Christoph Klein; Deanna Nguyen; Ching-Hui Liu; Atsushi Mizoguchi; Atul K Bhan; Hiroaki Miki; Tadaomi Takenawa; Fred S Rosen; Fred W Alt; Richard C Mulligan; Scott B Snapper Journal: Blood Date: 2002-11-14 Impact factor: 22.113
Authors: Kathryn T Chen; Madhu S Malo; Angela K Moss; Skye Zeller; Paul Johnson; Farzad Ebrahimi; Golam Mostafa; Sayeda N Alam; Sundaram Ramasamy; H Shaw Warren; Elizabeth L Hohmann; Richard A Hodin Journal: Am J Physiol Gastrointest Liver Physiol Date: 2010-05-20 Impact factor: 4.052
Authors: X Wang; J Wang; S C Wong; L S Chow; J M Nicholls; Y C Wong; Y Liu; D L Kwong; J S Sham; S W Tsa Journal: Life Sci Date: 2000-10-20 Impact factor: 5.037
Authors: Ben E Biesterveld; Shannon M Koehler; Nathan P Heinzerling; Rebecca M Rentea; Katherine Fredrich; Scott R Welak; David M Gourlay Journal: J Surg Res Date: 2015-02-19 Impact factor: 2.192
Authors: David A Shifrin; Russell E McConnell; Rajalakshmi Nambiar; James N Higginbotham; Robert J Coffey; Matthew J Tyska Journal: Curr Biol Date: 2012-03-01 Impact factor: 10.834
Authors: Wei Liu; Dong Hu; Haizhong Huo; Weifeng Zhang; Fatemeh Adiliaghdam; Sarah Morrison; Juan M Ramirez; Sarah S Gul; Sulaiman R Hamarneh; Richard A Hodin Journal: J Am Coll Surg Date: 2015-12-18 Impact factor: 6.113
Authors: Robert J Ardecky; Ekaterina V Bobkova; Tina Kiffer-Moreira; Brock Brown; Santhi Ganji; Jiwen Zou; Ian Pass; Sonoko Narisawa; Flávia Godoy Iano; Craig Rosenstein; Anton Cheltsov; Justin Rascon; Michael Hedrick; Carlton Gasior; Anita Forster; Shenghua Shi; Russell Dahl; Stefan Vasile; Ying Su; Eduard Sergienko; Thomas D Y Chung; Jonathan Kaunitz; Marc F Hoylaerts; Anthony B Pinkerton; José Luis Millán Journal: Bioorg Med Chem Lett Date: 2013-12-19 Impact factor: 2.823
Authors: Farzad Ebrahimi; Madhu S Malo; Sayeda Nasrin Alam; Angela K Moss; Halim Yammine; Sundaram Ramasamy; Brishti Biswas; Kathryn T Chen; Nur Muhammad; Golam Mostafa; H Shaw Warren; Elizabeth L Hohmann; Richard A Hodin Journal: J Gastrointest Surg Date: 2011-03-01 Impact factor: 3.452